Deutsche Bank AG reissued their buy rating on shares of Monsanto Co. (NYSE:MON) in a report released on Thursday morning.
A number of other equities research analysts have also weighed in on MON. Zacks Investment Research raised Monsanto from a sell rating to a hold rating in a research note on Wednesday, June 8th. Piper Jaffray Cos. reissued an overweight rating and issued a $127.00 target price (up previously from $95.00) on shares of Monsanto in a research note on Monday, June 13th. Argus reissued a buy rating and issued a $128.00 target price (up previously from $111.00) on shares of Monsanto in a research note on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 target price on Monsanto and gave the company a sell rating in a research note on Monday, June 27th. Finally, Vetr raised Monsanto from a buy rating to a strong-buy rating and set a $116.55 target price for the company in a research note on Monday, June 27th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $114.65.
Shares of Monsanto (NYSE:MON) opened at 103.33 on Thursday. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The firm has a 50-day moving average price of $104.80 and a 200-day moving average price of $101.69. The firm has a market cap of $45.23 billion, a PE ratio of 34.58 and a beta of 1.19.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same period in the prior year, the business earned ($0.19) EPS. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, equities research analysts predict that Monsanto will post $4.89 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a yield of 2.09%. Monsanto’s dividend payout ratio is 71.05%.
In other Monsanto news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.88% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock valued at $3,146,826,000 after buying an additional 389,914 shares in the last quarter. State Street Corp increased its position in Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock worth $1,634,002,000 after buying an additional 173,201 shares during the period. FMR LLC increased its position in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Massachusetts Financial Services Co. MA increased its position in Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the period. Finally, Capital International Investors increased its position in Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the period. Institutional investors and hedge funds own 79.02% of the company’s stock.